메뉴 건너뛰기




Volumn 94, Issue SUPPL. 1, 2012, Pages 61-64

Subgroup analyses: When should we believe them?

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; HUMAN; HYPOTHESIS; MEDICAL RESEARCH; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SUBGROUP ANALYSIS; ADJUVANT CHEMOTHERAPY; ARTICLE; DECISION MAKING; EVIDENCE BASED MEDICINE; FEMALE; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; ORTHOPEDICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; SARCOMA; SEXUAL DEVELOPMENT; STATISTICAL ANALYSIS; STATISTICS;

EID: 84866935688     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.00272     Document Type: Review
Times cited : (5)

References (18)
  • 1
    • 34548144593 scopus 로고    scopus 로고
    • Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults
    • Sarcoma Meta-analysis Collaboration (SMAC)
    • Sarcoma Meta-analysis Collaboration (SMAC). Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Cochrane Database Syst Rev. 2000;CD001419.
    • (2000) Cochrane Database Syst Rev
  • 2
    • 73449129773 scopus 로고    scopus 로고
    • How to work with a subgroup analysis
    • Evidence-Based Surgery Working Group
    • Dijkman B, Kooistra B, Bhandari M; Evidence-Based Surgery Working Group. How to work with a subgroup analysis. Can J Surg. 2009;52:515-22.
    • (2009) Can J Surg , vol.52 , pp. 515-522
    • Dijkman, B.1    Kooistra, B.2    Bhandari, M.3
  • 3
    • 11844302840 scopus 로고    scopus 로고
    • Treating individuals 2: Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation
    • DOI 10.1016/S0140-6736(05)17709-5, PII S0140673605177095
    • Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005;365:176-86. (Pubitemid 40091809)
    • (2005) Lancet , vol.365 , Issue.9454 , pp. 176-186
    • Rothwell, P.M.1
  • 4
    • 67649977705 scopus 로고    scopus 로고
    • Outcome based subgroup analysis: A neglected concern
    • Hirji KF, Fagerland MW. Outcome based subgroup analysis: a neglected concern. Trials. 2009;10:33.
    • (2009) Trials , vol.10 , pp. 33
    • Hirji, K.F.1    Fagerland, M.W.2
  • 5
    • 0037108235 scopus 로고    scopus 로고
    • Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems
    • Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002;21:2917-30.
    • (2002) Stat Med , vol.21 , pp. 2917-2930
    • Pocock, S.J.1    Assmann, S.E.2    Enos, L.E.3    Kasten, L.E.4
  • 6
    • 0034712491 scopus 로고    scopus 로고
    • Subgroup analysis and other (mis)uses of baseline data in clinical trials
    • Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355:1064-9. (Pubitemid 30162810)
    • (2000) Lancet , vol.355 , Issue.9209 , pp. 1064-1069
    • Assmann, S.F.1    Pocock, S.J.2    Enos, L.E.3    Kasten, L.E.4
  • 7
    • 77951082212 scopus 로고    scopus 로고
    • Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
    • doi:10.1136/bmj.c117
    • Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010;340:c117. doi:10.1136/bmj.c117.
    • (2010) BMJ , vol.340
    • Sun, X.1    Briel, M.2    Walter, S.D.3    Guyatt, G.H.4
  • 9
    • 0026501239 scopus 로고
    • A consumer's guide to subgroup analyses
    • Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78-84.
    • (1992) Ann Intern Med , vol.116 , pp. 78-84
    • Oxman, A.D.1    Guyatt, G.H.2
  • 10
    • 0034466679 scopus 로고    scopus 로고
    • Debate: Subgroup analyses in clinical trials - Fun to look at, but don't believe them!
    • DOI 10.1186/CVM-1-1-025, 025
    • Sleight P. Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! Curr Control Trials Cardiovasc Med. 2000;1:25-27. (Pubitemid 32219871)
    • (2000) Current Controlled Trials in Cardiovascular Medicine , vol.1 , Issue.1 , pp. 25-27
    • Sleight, P.1
  • 11
    • 10744220809 scopus 로고    scopus 로고
    • How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)
    • DOI 10.1023/B:CEPR.0000012438.04416.00
    • Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Card Electrophysiol Rev. 2003;7:264-75. (Pubitemid 38256110)
    • (2003) Cardiac Electrophysiology Review , vol.7 , Issue.3 , pp. 264-275
    • Wikstrand, J.1    Wedel, H.2    Ghali, J.3    Deedwania, P.4    Fagerberg, B.5    Goldstein, S.6    Gottlieb, S.7    Hjalmarson, A.8    Kjekshus, J.9    Waagstein, F.10
  • 12
    • 0031006966 scopus 로고    scopus 로고
    • P-value adjustments for subgroup analyses
    • discussion 323-31
    • Bristol DR. p-value adjustments for subgroup analyses. J Biopharm Stat. 1997; 7:313-21; discussion 323-31.
    • (1997) J Biopharm Stat , vol.7 , pp. 313-321
    • Bristol, D.R.1
  • 14
    • 0037374008 scopus 로고    scopus 로고
    • Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses
    • Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326:472.
    • (2003) BMJ , vol.326 , pp. 472
    • Song, F.1    Altman, D.G.2    Glenny, A.M.3    Deeks, J.J.4
  • 15
    • 1842453957 scopus 로고    scopus 로고
    • Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test
    • DOI 10.1016/j.jclinepi.2003.08.009, PII S0895435603003329
    • Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol. 2004;57:229-36. (Pubitemid 38456874)
    • (2004) Journal of Clinical Epidemiology , vol.57 , Issue.3 , pp. 229-236
    • Brookes, S.T.1    Whitely, E.2    Egger, M.3    Smith, G.D.4    Mulheran, P.A.5    Peters, T.J.6
  • 16
    • 0043240363 scopus 로고    scopus 로고
    • Predictive variables detailing the recurrence rate of soft tissue sarcomas
    • DOI 10.1097/00001622-200307000-00007
    • Grobmyer SR, Brennan MF. Predictive variables detailing the recurrence rate of soft tissue sarcomas. Curr Opin Oncol. 2003;15:319-26. (Pubitemid 36994037)
    • (2003) Current Opinion in Oncology , vol.15 , Issue.4 , pp. 319-326
    • Grobmyer, S.R.1    Brennan, M.F.2
  • 17
    • 0036467991 scopus 로고    scopus 로고
    • Postoperative nomogram for 12-year sarcoma-specific death
    • DOI 10.1200/JCO.20.3.791
    • Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791-6. (Pubitemid 34111387)
    • (2002) Journal of Clinical Oncology , vol.20 , Issue.3 , pp. 791-796
    • Kattan, M.W.1    Leung, D.H.Y.2    Brennan, M.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.